The Food and Drug Administration (FDA) has released a draft guidance titled “Rare Diseases: Natural History Studies for Drug Development” with the intention to inform both the design and execution of natural history studies to support the development of safe and...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
